Navigation Links
Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke
Date:9/11/2013

The population of northeastern China has a high incidence of ischemic stroke. Previous studies have shown that intracranial large-artery atherosclerosis is one of the main causes of ischemic stroke, and that the mechanisms are related to inflammation and thrombosis of the affected arteries. A recent study by Lianqiu Min and colleagues from Liaoning Medical University observed the effects of atorvastatin treatment in 89 patients from northeastern China with acute ischemic stroke caused by intracranial large-artery atherosclerosis by measuring changes in the levels of markers of inflammation, thrombogenesis, and hyperlipidemia. The researchers found that atorvastatin treatment decreased the levels of markers of inflammation, thrombogenesis, and hyperlipidemia, suggesting that atorvastatin reduces inflammation and thrombogenesis independent of its lipid-lowering effects in patients with acute ischemic stroke caused by large-artery atherosclerosis. Most previous studies of patients with acute ischemic stroke caused by large-artery atherosclerosis focused mainly on measurement of the level of a single marker such as C-reactive protein, fibrinogen, or D-dimer. The study, reported by Lianqiu Min and colleagues in the Neural Regeneration Research (Vol. 8, No. 23, 2013), measured all three of these values to evaluate the effects of atorvastatin treatment, and expanded the range of atorvastatin available for the treatment of acute ischemic stroke.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert

Page: 1

Related medicine news :

1. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
2. New anti-inflammatory drugs pinch off reactive oxygen species at the source
3. NIH launches trial to evaluate anti-inflammatory treatment for preventing heart attacks, strokes, and cardiovascular deaths
4. Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
5. Do non-steroidal anti-inflammatory drugs cause kidney failure in children?
6. Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing
7. Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing
8. Young girls more likely to report side effects after HPV vaccine
9. Preteens More Likely to Report HPV Vaccine Side Effects
10. Breast cancer patients suffer treatment-related side effects long after completing care
11. Breast Cancer Treatment Side Effects May Last for Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Los Angeles, CA (PRWEB) , ... January 18, 2017 , ... ... serious hazards while driving during a rain storm by slowing down and increasing the ... published on Fox 40. Los Angeles based car accident attorney Raymond R. Hassanlou notes ...
(Date:1/19/2017)... ... 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, ... Over the past 20 years SFI has been recognized as the world’s leader in ... clients into the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, ...
(Date:1/19/2017)... , ... January 19, 2017 ... ... member of the American Osteopathic College of Proctology) announced today the opening ... throughout Southern California ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly ...
(Date:1/18/2017)... ... January 18, 2017 , ... From a health perspective, 2017 will ... linking gut health to chronic disease, mental health and general physical well-being. The New ... important resolution to consider. , For one Charlottesville restaurant, good gut health is clearly ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... journal and most-read publication among specialty pharmacists and pharmacy professionals, has teamed ... Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of Pharmacy Healthcare ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  Magnetic Insight Inc., leader in magnetic ... agreement with inviCRO LLC to develop intuitive image ... based on inviCRO,s VivoQuant™ visualization and post processing ... complete MPI solution package with the Momentum MPI ... imaging in vivo. MPI is a ...
(Date:1/18/2017)... 18, 2017  EnteroMedics Inc. (NASDAQ: ... neuroblocking technology to treat obesity, metabolic diseases and ... an underwritten public offering of units for gross ... discounts and commissions and offering expenses payable by ... Class A Units, priced at a public offering ...
Breaking Medicine Technology: